- Home
- IMMP vs RMR Comparison
IMMP vs RMR Comparison
Compare IMMP & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- RMR
- Stock Information
- Founded
- IMMP 1987
- RMR 1986
- Country
- IMMP Australia
- RMR United States
- Employees
- IMMP N/A
- RMR N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- RMR Professional Services
- Sector
- IMMP Health Care
- RMR Consumer Discretionary
- Exchange
- IMMP Nasdaq
- RMR Nasdaq
- Market Cap
- IMMP 304.0M
- RMR 347.9M
- IPO Year
- IMMP N/A
- RMR N/A
- Fundamental
- Price
- IMMP $1.93
- RMR $19.76
- Analyst Decision
- IMMP Buy
- RMR Buy
- Analyst Count
- IMMP 2
- RMR 2
- Target Price
- IMMP $8.50
- RMR $32.00
- AVG Volume (30 Days)
- IMMP 98.7K
- RMR 117.6K
- Earning Date
- IMMP 02-27-2025
- RMR 02-05-2025
- Dividend Yield
- IMMP N/A
- RMR 9.11%
- EPS Growth
- IMMP N/A
- RMR N/A
- EPS
- IMMP N/A
- RMR 1.38
- Revenue
- IMMP $2,563,302.00
- RMR $196,924,000.00
- Revenue This Year
- IMMP N/A
- RMR $379.19
- Revenue Next Year
- IMMP $47.79
- RMR $2.01
- P/E Ratio
- IMMP N/A
- RMR $14.32
- Revenue Growth
- IMMP 9.59
- RMR N/A
- 52 Week Low
- IMMP $1.66
- RMR $19.08
- 52 Week High
- IMMP $3.34
- RMR $26.82
- Technical
- Relative Strength Index (RSI)
- IMMP 42.28
- RMR 36.55
- Support Level
- IMMP $2.00
- RMR $19.25
- Resistance Level
- IMMP $2.05
- RMR $20.00
- Average True Range (ATR)
- IMMP 0.09
- RMR 0.50
- MACD
- IMMP -0.02
- RMR 0.04
- Stochastic Oscillator
- IMMP 8.33
- RMR 35.98
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.